Levels
Levels is a Continuous Glucose & Metabolic company founded in 2019 and based in New York, United States. It has raised $38M in total funding, most recently a Series A in 2022 at a $300M valuation.
Founded in 2019, Levels builds a metabolic-health software layer on top of continuous glucose monitors (CGMs), translating real-time glucose data into personalized insights about how food, exercise, sleep, and stress affect a user's blood sugar. The company raised a $38M Series A in 2022 at a roughly $300M valuation, followed by a $10M Series A extension in 2024 backed by Andreessen Horowitz, taking total funding to around $50M. Co-founders include Sam Corcos (CEO), Casey Means MD, and Josh Clemente. Levels markets to the non-diabetic wellness and prediabetes audience seeking to optimize metabolic fitness.
Levels helped define the consumer metabolic-health category, turning prescription CGM hardware into a wellness software subscription for non-diabetics.
At a glance
Total raised
$38M
Headcount
11-50
Headquarters
New York
United StatesFounded
2019
Status
Private
Latest valuation
Where Levels ranks
Top 25 Wearables companies →Funding history
Total raised
$38M
Rounds tracked
1
Latest stage
Series A
Latest valuation
$300M
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Apr 20, 2022 | Series A | $38M | $300M | — |